Skip to main content
. 2018 Jan 11;13(1):e0190887. doi: 10.1371/journal.pone.0190887

Table 2. Serum ceruloplasmin levels in patients with various diseases.

Classification of diseases Ceruloplasmin level (mg/L)
Mean 0- 50- 100- 150- ≥200
Acute hepatitis (n = 62) 378.6±115.9 0 0 0 0 62
Chronic hepatitis (n = 228) 249.3±88.2 0 0 9 53 166
Cirrhosis (n = 490) 260.9±85.0 0 0 25 101 364
Acute and subacute liver failure (n = 162) 200.8±55.3 0 0 23 72 67
Chronic liver failure (n = 183) 218.6±73.8 0 3 16 69 95
Drug-induced hepatitis (n = 60) 340.9±113.1 0 0 1 4 55
Autoimmune hepatitis (n = 44) 321.2±119.5 0 0 0 2 42
Primary biliary cirrhosis (n = 44) 360.8±120.5 0 0 0 4 40
Alcoholic liver disease and NAFLD (n = 142) 283.4±81.3 0 0 7 16 119
Other digestive tract diseases (n = 129) 307.0±107.5 0 0 5 11 113
Nephrotic syndrome (n = 324) 235.4±88.3 2 5 38 77 202
Purpura nephritis (n = 120) 263.1±77.9 0 0 6 18 96
Other kidney disease (n = 160) 283.2±75.3 0 0 2 16 142
Parkinsonism (n = 16) 281.9±60.8 0 0 0 2 14
Schizophrenia (n = 28) 262.7±73.7 0 0 1 3 24
Depression (n = 12) 254.3±72.6 0 0 0 1 11
Epilepsy (n = 103) 278.2±69.6 0 0 1 8 94
Autonomic nervous dysfunction (n = 28) 263.9±68.0 0 0 0 3 25
Myasthenia gravis (n = 64) 283.1±62.0 0 0 0 3 61
Other nervous, mental disorders (n = 167) 275.8±67.0 0 0 4 16 147
Purpura (n = 156) 294.7±78.8 0 0 4 13 139
Connective tissue diseases (n = 124) 353.2±140.7 0 0 2 8 114
Mucocutaneous lymph node (n = 11) 452.3±155.7 0 0 0 0 11
Cardiovascular disease (n = 77) 304.0±101.4 0 0 3 8 66
Hyperthyroidism (n = 32) 375.3±156.2 0 0 0 1 31
Diabetes mellitus (n = 27) 286.9±81.5 0 0 0 3 24
Sepsis (n = 81) 381.2±119.0 0 0 0 3 78
Pneumonitis and bronchiolitis (n = 158) 338.8±91.7 0 0 1 6 151
Infectious mononucleosis (n = 15) 415.5±86.5 0 0 0 0 15
Intracranial infection (n = 121) 314.6±104.6 0 0 0 7 114
Pregnancy (n = 47) 623.4±218.5 0 0 0 0 47
Malignant tumor and leukemia (n = 229) 392.1±152.5 0 1 2 12 214
Other diseases (n = 107) 326.8±124.0 0 2 2 13 90
Total (n = 3751) 293.2±117.3 2 11 152 553 3033

NAFLD; nonalcoholic fatty liver disease